Bioinformatics Approach to BDNF and BDNF-Related Disorders

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2011
Editora
BENTHAM SCIENCE PUBL LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
CURRENT NEUROPHARMACOLOGY, v.9, n.2, p.318-329, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Context: Currently, the keyword 'BDNF' retrieves 7388 publications in Pubmed, which point to many directions. Objective: This paper aims to uncover patterns that are hidden under this huge mass of studies and then to review the most prominent sub-topics in 'BDNF and mental health'. Method: Several semi-automatic tools employed, in order to present: 1. A visual representation of BDNF's main molecular pathways; 2. A table with all the components of this pathway that are known to be associated with human diseases; 3. A conceptual map of the whole literature; 4. A histogram of the mental disorders that are known to be associated with BDNF, as well as a review of the literature on each one of these topics. Results: The conceptual map suggests that the field is divided in two major sections: BDNF molecular pathways, receptors, other neurotrophins and neurotransmitters; and BDNF-related disorders. Among the latter, the mental disorders that are mostly related to BDNF are: depression, schizophrenia, Parkinson disease, Alzheimer disease, and bipolar disorder.
Palavras-chave
BDNF, genetic neuroscience, bioinformatics, data mining, review
Referências
  1. Akil H, 2008, Novartis Found Symp, V289, P94
  2. Alfonso J, 2005, REV NEUROSCIENCE, V16, P43
  3. Andereggen L, 2009, BRAIN RES, V1276, P39, DOI 10.1016/j.brainres.2009.04.021
  4. Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024
  5. Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2
  6. Agartz I, 2006, AM J MED GENET B, V141B, P513, DOI 10.1002/ajmg.b.30338
  7. Bozdagi O, 2008, J NEUROSCI, V28, P9857, DOI 10.1523/JNEUROSCI.3145-08.2008
  8. Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864
  9. Luchsinger JA, 2009, J ALZHEIMERS DIS, V16, P693, DOI 10.3233/JAD-2009-1022
  10. Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019
  11. Rainero I, 2004, NEUROBIOL AGING, V25, P1293, DOI 10.1016/j.neurobiolaging.2004.02.011
  12. Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3
  13. Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X
  14. Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369
  15. Numakawa T, 1999, BRAIN RES, V842, P431, DOI 10.1016/S0006-8993(99)01867-3
  16. Ikram MA, 2009, BIOL PSYCHIAT, V65, P995, DOI 10.1016/j.biopsych.2008.11.014
  17. Delgado PL, 2000, J CLIN PSYCHIAT, V61, P7
  18. Shi JJ, 2008, PSYCHIAT GENET, V18, P116, DOI 10.1097/YPG.0b013e3282fa184b
  19. Pleschka S, 2008, BIOL CHEM, V389, P1273, DOI 10.1515/BC.2008.145
  20. Maraganore DM, 2004, ANN NEUROL, V55, P512, DOI 10.1002/ana.20017
  21. Wright IC, 2000, AM J PSYCHIAT, V157, P16
  22. Sharma A, 2006, CANCER RES, V66, P8200, DOI 10.1158/0008-5472.CAN-06-0809
  23. Wessa M, 2009, BIPOLAR DISORD, V11, P504, DOI 10.1111/j.1399-5618.2009.00718.x
  24. Fenelon G, 2000, BRAIN, V123, P733, DOI 10.1093/brain/123.4.733
  25. Collier DA, 2003, EUR J PHARMACOL, V480, P177, DOI 10.1016/j.ephar.2003.08.105
  26. Elkins JS, 2004, NEUROLOGY, V62, P363
  27. Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025
  28. Jo SA, 2008, DEMENT GERIATR COGN, V25, P165, DOI 10.1159/000112918
  29. Chandra V, 1998, NEUROLOGY, V51, P1000
  30. Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309
  31. Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001
  32. Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8
  33. Molina V, 2003, PSYCHIAT RES-NEUROIM, V124, P163, DOI 10.1016/S0925-4927(03)00107-0
  34. ARNDT S, 1991, BRIT J PSYCHIAT, V158, P317, DOI 10.1192/bjp.158.3.317
  35. Carter CJ, 2007, SCHIZOPHRENIA BULL, V33, P1343, DOI 10.1093/schbul/sbm007
  36. Anttila S, 2007, J NEURAL TRANSM, V114, P1065, DOI 10.1007/s00702-007-0705-9
  37. Pae HO, 2001, IN VITRO MOL TOXICOL, V14, P99
  38. Kitamura Y, 1998, BRAIN RES, V780, P260, DOI 10.1016/S0006-8993(97)01202-X
  39. Lehmann DJ, 2005, AM J EPIDEMIOL, V162, P305, DOI 10.1093/aje/kwi202
  40. Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
  41. Jiang XY, 2005, NEUROPSYCHOPHARMACOL, V30, P1353, DOI 10.1038/sj.npp.1300703
  42. Ueyama T, 1997, NEUROSCI RES, V28, P103, DOI 10.1016/S0168-0102(97)00030-8
  43. Colla M, 2007, J PSYCHIATR RES, V41, P553, DOI 10.1016/j.jpsychires.2006.06.011
  44. Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109
  45. von Campenhausen S, 2005, EUR NEUROPSYCHOPHARM, V15, P473, DOI 10.1016/j.euroneuro.2005.04.007
  46. Gatt JM, 2008, BIOL PSYCHOL, V79, P275, DOI 10.1016/j.biopsycho.2008.07.004
  47. Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912
  48. Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
  49. Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007
  50. Sussmann JE, 2009, BIPOLAR DISORD, V11, P11, DOI 10.1111/j.1399-5618.2008.00646.x
  51. Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552
  52. Olsson CA, 2005, MOL PSYCHIATR, V10, P868, DOI 10.1038/sj.mp.4001677
  53. SAGOT Y, 1995, J NEUROSCI, V15, P7727
  54. Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677
  55. Chen L, 2008, AM J MED GENET B, V147B, P814, DOI 10.1002/ajmg.b.30686
  56. Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614
  57. Bruno S, 2008, BIPOLAR DISORD, V10, P460, DOI 10.1111/j.1399-5618.2007.00552.x
  58. Ying SW, 2002, J NEUROSCI, V22, P1532
  59. Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
  60. Zhang ZZ, 2009, J NEURAL TRANSM, V116, P1193, DOI 10.1007/s00702-009-0260-7
  61. Lasky-Su JA, 2005, AM J MED GENET B, V133B, P110, DOI 10.1016/j.ajmg.b.30104
  62. Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022
  63. KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8
  64. Mantere O, 2008, BIPOLAR DISORD, V10, P413, DOI 10.1111/j.1399-5618.2007.00502.x
  65. Olsen CC, 2009, AM J CLIN ONCOL-CANC, V32, P115, DOI 10.1097/COC.0b013e318180baa3
  66. Grube BS, 1998, SCHIZOPHR RES, V31, P113, DOI 10.1016/S0920-9964(98)00011-5
  67. Smith MA, 1995, ANN NY ACAD SCI, V771, P234, DOI 10.1111/j.1749-6632.1995.tb44684.x
  68. Chen C, 2008, BIPOLAR DISORD, V10, P816, DOI 10.1111/j.1399-5618.2008.00623.x
  69. Autry AE, 2009, BIOL PSYCHIAT, V66, P84, DOI 10.1016/j.biopsych.2009.02.007
  70. Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3
  71. Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543
  72. Altar CA, 1999, TRENDS PHARMACOL SCI, V20, P59, DOI 10.1016/S0165-6147(99)01309-7
  73. Lencz T, 2009, BRIT J PSYCHIAT, V194, P313, DOI 10.1192/bjp.bp.108.050401
  74. Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637
  75. deRijk MC, 1995, NEUROLOGY, V45, P2143
  76. Sawaishi Y, 2009, BRAIN DEV-JPN, V31, P493, DOI 10.1016/j.braindev.2009.03.006
  77. Araujo AP, 2009, DNA CELL BIOL, V28, P265, DOI 10.1089/dna.2008.0823
  78. BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B
  79. Blanquet PR, 2003, NEUROSCIENCE, V118, P477, DOI 10.1016/S0306-4522(02)00963-6
  80. Castellanos-Ortega M R, 1999, Rev Neurol, V29, P439
  81. Chemerinski E, 2006, SCHIZOPHR RES, V85, P12, DOI 10.1016/j.schres.2006.03.002
  82. DELBO R, 2006, NEUROBIOL AGING, V27, pE770
  83. Deng Y S, 2000, Neurotox Res, V1, P311
  84. Duan SW, 2005, NEUROSCI LETT, V379, P32, DOI 10.1016/j.neulet.2004.12.040
  85. Dutta R, 2007, BRAIN, V130, P2566, DOI 10.1093/brain/awm206
  86. Fan Jinbo, 2008, Novartis Found Symp, V289, P60
  87. Frith C, 1996, BRIT MED BULL, V52, P618
  88. Fukuyama H, 2004, J NEUROL, V251, P1, DOI 10.1007/s00415-004-1702-7
  89. Glatt SJ, 2006, AM J MED GENET B, V141B, P149, DOI 10.1002/ajmg.b.30273
  90. Healy DG, 2004, J NEUROL NEUROSUR PS, V75, P962, DOI 10.1136/jnnp.2003.026203
  91. Hoefgen B, 2005, BIOL PSYCHIAT, V57, P247, DOI 10.1016/j.biopsych.2004.11.027
  92. Hünnerkopf Regina, 2007, Neuropsychopharmacology, V32, P2552, DOI 10.1038/sj.npp.1301383
  93. Jablensky A, 1988, Acta Psychiatr Scand Suppl, V344, P65
  94. Johnstone EC, 1996, PSYCHOL MED, V26, P669
  95. Kasselman LJ, 2006, J NEUROIMMUNOL, V175, P118, DOI 10.1016/j.jneuroim.2006.03.008
  96. Kaushansky Kenneth, 2005, Hematology Am Soc Hematol Educ Program, P533
  97. Kumakiri C, 1999, NEUROSCI LETT, V263, P205, DOI 10.1016/S0304-3940(99)00098-1
  98. Lachman HM, 2006, NEUROPSYCHOBIOLOGY, V53, P57, DOI 10.1159/000091720
  99. Li ZJ, 2005, CANCER RES, V65, P2070, DOI 10.1158/0008-5472.CAN-04-3606
  100. Lovlie R, 2001, PSYCHIATR GENET, V11, P41, DOI 10.1097/00041444-200103000-00008
  101. Luckhaus C, 2007, AGING CLIN EXP RES, V19, P165
  102. McCann SJ, 1997, J NEUROL SCI, V153, P50, DOI 10.1016/S0022-510X(97)00179-2
  103. Mellick GD, 2005, NEUROSCI LETT, V375, P112, DOI 10.1016/j.neulet.2004.10.078
  104. Nakabayashi TIK, 2008, REV PSIQUIATR CLIN, V35, P219, DOI 10.1590/S0101-60832008000600003
  105. Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067
  106. Ntais C, 2005, J NEUROL, V252, P1276, DOI 10.1007/s00415-005-0823-y
  107. Perticone F, 2009, J HYPERTENS, V27, P613, DOI 10.1097/HJH.0b013e32831fda24
  108. Philibert RA, 2006, PSYCHIAT GENET, V16, P73, DOI 10.1097/01.ypg.0000194443.81813.f0
  109. POON WW, 2009, NEUROBIOL A IN PRESS, DOI 10.1016/J.NEUROBIOLOGING
  110. Prasher VP, 1997, AM J MENT RETARD, V102, P103, DOI 10.1352/0895-8017(1997)102<0103:AGAADI>2.0.CO;2
  111. Raepple D, 2009, ANN HEMATOL, V88, P319, DOI 10.1007/s00277-008-0593-6
  112. Rodriguez-Manotas M, 2007, BRAIN RES, V1170, P119, DOI 10.1016/j.brainres.2007.07.032
  113. SCACCHI R, 2008, AM J MED GENET B, V150, P502
  114. Schondorf T, 2002, INT J ONCOL, V20, P273
  115. Serretti A, 2005, PSYCHIAT RES, V134, P191, DOI 10.1016/j.psychres.2005.01.006
  116. Stern AJ, 2008, BIOL PSYCHIAT, V64, P856, DOI 10.1016/j.biopsych.2008.07.009
  117. Strickland D, 2004, MOVEMENT DISORD, V19, P318, DOI 10.1002/mds.10619
  118. Taylor WD, 2008, AM J GERIAT PSYCHIAT, V16, P263, DOI 10.1097/JGP.0b013e3181591c30
  119. Wang DM, 2001, IMMUNOGENETICS, V53, P550, DOI 10.1007/s002510100356
  120. Williams J, 1998, MOL PSYCHIATR, V3, P141, DOI 10.1038/sj.mp.4000376
  121. Yamaguchi H, 2002, AM J HEMATOL, V69, P74, DOI 10.1002/ajh.10030
  122. Yu Y, 2006, MOL CELL BIOL, V26, P6372, DOI 10.1128/MCB.00509-05
  123. Zhang J, 2005, EUR NEUROL, V53, P15, DOI 10.1159/000082956
  124. Zintzaras E, 2004, J HUM GENET, V49, P474, DOI 10.1007/s10038-004-0176-x